Evaluation of a Text Message-Based COVID-19 Vaccine Outreach Program Among Older Patients: Cross-sectional Study.
SMS
appointment
cross-sectional
effectiveness
elderly
elderly patients
engagement
evaluation
older adults
smartphone
text message
text messaging
vaccine
vaccine outreach
Journal
JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394
Informations de publication
Date de publication:
18 Jul 2022
18 Jul 2022
Historique:
received:
30
08
2021
accepted:
16
06
2022
revised:
06
01
2022
pubmed:
21
6
2022
medline:
21
6
2022
entrez:
20
6
2022
Statut:
epublish
Résumé
COVID-19 vaccines are vital tools in the defense against infection and serious disease due to SARS-CoV-2. There are many challenges to implementing mass vaccination campaigns for large, diverse populations from crafting vaccine promotion messages to reaching individuals in a timely and effective manner. During this unprecedented period, with COVID-19 mass vaccination campaigns essential for protecting vulnerable patient populations and attaining herd immunity, health care systems were faced with the dual challenges of vaccine outreach and distribution. The aim of this cross-sectional study was to assess the effectiveness of a COVID-19 vaccine text outreach approach for patients aged 65 years and older. Our goal was to determine whether this approach was successful in scheduling patients for COVID-19 vaccine appointments. We developed SMS text messages using the Tavoca platform. These messages informed patients of their vaccine eligibility and allowed them to indicate their interest in scheduling an appointment via a specific method (email or phone) or indicate their lack of interest in the vaccine. We tracked the status of these messages and how patients responded. Messages were sent to patients aged 65 years and older (N=30,826) at a nonprofit health care system in Washington, DC. Data were collected and examined from January 14 to May 10, 2021. Data were analyzed using multivariate multinomial and binary logistic regression models in SAS (version 9.4; SAS Institute Inc). Approximately 57% of text messages were delivered to patients, but many messages received no response from patients (40%). Additionally, 42.1% (12,978/30,826) of messages were not delivered. Of the patients who expressed interest in the vaccine (2938/30,826, 9.5%), Black or African American patients preferred a phone call rather than an email for scheduling their appointment (odds ratio [OR] 1.69, 95% CI 1.29-2.21) compared to White patients. Patients aged 70-74 years were more likely to schedule an appointment (OR 1.38, 95% CI 1.01-1.89) than those aged 65-69 years, and Black or African American patients were more likely to schedule an appointment (OR 2.90, 95% CI 1.72-4.91) than White patients. This study provides insights into some advantages and challenges of using a text messaging vaccine outreach for patients aged 65 years and older. Lessons learned from this vaccine campaign underscore the importance of using multiple outreach methods and sharing of patient vaccination status between health systems, along with a patient-centered approach to address vaccine hesitancy and access issues.
Sections du résumé
BACKGROUND
BACKGROUND
COVID-19 vaccines are vital tools in the defense against infection and serious disease due to SARS-CoV-2. There are many challenges to implementing mass vaccination campaigns for large, diverse populations from crafting vaccine promotion messages to reaching individuals in a timely and effective manner. During this unprecedented period, with COVID-19 mass vaccination campaigns essential for protecting vulnerable patient populations and attaining herd immunity, health care systems were faced with the dual challenges of vaccine outreach and distribution.
OBJECTIVE
OBJECTIVE
The aim of this cross-sectional study was to assess the effectiveness of a COVID-19 vaccine text outreach approach for patients aged 65 years and older. Our goal was to determine whether this approach was successful in scheduling patients for COVID-19 vaccine appointments.
METHODS
METHODS
We developed SMS text messages using the Tavoca platform. These messages informed patients of their vaccine eligibility and allowed them to indicate their interest in scheduling an appointment via a specific method (email or phone) or indicate their lack of interest in the vaccine. We tracked the status of these messages and how patients responded. Messages were sent to patients aged 65 years and older (N=30,826) at a nonprofit health care system in Washington, DC. Data were collected and examined from January 14 to May 10, 2021. Data were analyzed using multivariate multinomial and binary logistic regression models in SAS (version 9.4; SAS Institute Inc).
RESULTS
RESULTS
Approximately 57% of text messages were delivered to patients, but many messages received no response from patients (40%). Additionally, 42.1% (12,978/30,826) of messages were not delivered. Of the patients who expressed interest in the vaccine (2938/30,826, 9.5%), Black or African American patients preferred a phone call rather than an email for scheduling their appointment (odds ratio [OR] 1.69, 95% CI 1.29-2.21) compared to White patients. Patients aged 70-74 years were more likely to schedule an appointment (OR 1.38, 95% CI 1.01-1.89) than those aged 65-69 years, and Black or African American patients were more likely to schedule an appointment (OR 2.90, 95% CI 1.72-4.91) than White patients.
CONCLUSIONS
CONCLUSIONS
This study provides insights into some advantages and challenges of using a text messaging vaccine outreach for patients aged 65 years and older. Lessons learned from this vaccine campaign underscore the importance of using multiple outreach methods and sharing of patient vaccination status between health systems, along with a patient-centered approach to address vaccine hesitancy and access issues.
Identifiants
pubmed: 35724339
pii: v6i7e33260
doi: 10.2196/33260
pmc: PMC9295725
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e33260Informations de copyright
©Naheed Ahmed, Christian Boxley, Ram Dixit, Seth Krevat, Allan Fong, Raj M Ratwani, Deliya B Wesley. Originally published in JMIR Formative Research (https://formative.jmir.org), 18.07.2022.
Références
MMWR Morb Mortal Wkly Rep. 2022 Mar 04;71(9):335-340
pubmed: 35239636
JAMA. 2020 Jun 23;323(24):2458-2459
pubmed: 32421155
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33):
pubmed: 34326130
Am J Public Health. 2021 Jun;111(6):1073-1077
pubmed: 33950715
N Engl J Med. 2021 Jul 8;385(2):97-100
pubmed: 33789007
Vaccines (Basel). 2021 Oct 21;9(11):
pubmed: 34835152
Health Policy. 2021 May;125(5):553-567
pubmed: 33820678
Am J Health Syst Pharm. 2021 Feb 8;78(4):282-284
pubmed: 33555342
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1517-1521
pubmed: 33090984
Nature. 2021 Sep;597(7876):404-409
pubmed: 34340242
J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4):e230-e232
pubmed: 33858807
JAMA. 2021 Jun 15;325(23):2397-2399
pubmed: 34028495